A valuable Legacy

“The international scientific community carries out multidisciplinary, medical ­research with no regard for national borders. SWISS BRIDGE follows the same principle to seek financial support for this work, in order to intensify the ­international fight against cancer on all fronts, and to allow future generations to profit from the present advances being made.”

Prof. Dr Giorgio Noseda, Chairman of the Board of the Foundation

Our stated priority is to advance efforts to fight cancer with all available means.

Invests in cancer research worldwide
In the past ten years, we have supported numerous projects in Brazil, the UK, France, Italy, Norway, Sweden and Switzerland.

Generates over CHF 2 million in ­research funding every year
Banks in Switzerland have introduced numerous clients to SWISS BRIDGE, each of which has donated substantial amounts to SWISS BRIDGE.

Annual SWISS BRIDGE AWARD for ­international researchers
The SWISS BRIDGE Award has become one of Europe’s most important annual ­research awards. Only the best in class receive funding of up to CHF 500,000 for their future projects.

No expenses deducted from ­donations for research
Over the past ten years, the supporters and friends of the foundation have covered all the costs of public relations, fundraising and administration. This allows us to transfer 100 per cent of donations designated for research to the respective research teams.

World-class scientific standing
Both the Scientific Committee and the Patrons Committee include Nobel prize­winners and other world renowned scientists.

Close co-operation with the UICC
To enable international investors and international researchers to rate the quality of SWISS BRIDGE, the organisa­tion stipulates that recipients of SWISS BRIDGE ­funding outside Switzerland be a member of the Union Internationale Contre le ­Cancer in Geneva.

“Swissness” (trustworthy, modest and precise)
For over 10 years SWISS BRIDGE has under­taken only modest PR activities, putting it on the shortlist of the most efficient and successful platforms raising funds for cancer research.